Literature DB >> 20840875

Participation in randomised clinical trials is linked to emotion regulation strategies.

Tanguy Leroy1, Véronique Christophe, Nicolas Penel, Stéphanie Clisant, Pascal Antoine.   

Abstract

OBJECTIVES: Cancer patients' anxiety may curb their enrolment in clinical trials (CTs). Thus, the strategies they employ to reduce their anxiety may also determine their enrolment in CTs. The purposes of this study are (1) to compare the anxiety and emotion regulation strategies between patients who are enrolled in CTs (cases) and patients receiving standard cancer treatments who have never taken part in any CT (controls), and (2) to assess the links between these strategies and anxiety.
METHODS: In total, 76 cases and 108 controls completed two validated questionnaires assessing their emotion regulation style (ERQ) and anxiety (STAI-Y).
RESULTS: Overall, anxiety scores in cases and controls do not differ. The two groups do not differ in regards to their cognitive reappraisal of situations. However, cases inhibit their emotional expressions less than controls. Both cognitive reappraisal and emotional expressions are linked to lower scores of anxiety.
CONCLUSIONS: Patients enrolled in CTs do not seem to be more anxious than those receiving a standard treatment. However, cancer patients' anxiety depends on the emotion regulation strategies they use. Emotion regulation during physician-patient interactions should be investigated further as a possible factor for CT enrolment determination.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20840875     DOI: 10.1016/j.cct.2010.09.003

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  3 in total

1.  Distress among caregivers of phase I trial participants: a cross-sectional study.

Authors:  Elizabeth R Kessler; Angela Moss; S Gail Eckhardt; Mark L Laudenslager; Kristin Kilbourn; Iris B Mauss; Daniel W Bowles; Sharon Hecker; Diane L Fairclough; Jean S Kutner
Journal:  Support Care Cancer       Date:  2014-08-15       Impact factor: 3.603

2.  Affective science perspectives on cancer control: strategically crafting a mutually beneficial research agenda.

Authors:  Rebecca A Ferrer; Paige A Green; Lisa Feldman Barrett
Journal:  Perspect Psychol Sci       Date:  2015-05

3.  Affect regulation as a moderator of intentions for breast cancer chemoprevention.

Authors:  Claire C Conley; Doreen M Agnese; Susan T Vadaparampil; Suzanne C O'Neill; Barbara L Andersen
Journal:  J Behav Med       Date:  2022-02-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.